4
Changes in Ownership
Vericel Corp Filed Acc 0001593968-22-000613
Chief Medical Officer sold 16,738 shares at an average $41.43 ($693,431)
- Chief Medical Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark Chief Medical Officer | 2022-03-01 | Option exercise | +10,000 | $10.95 | $109,500 | 55,914 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2022-03-01 | Sale | −10,000 | $41.41 | $414,060 | 45,914 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2022-03-01 | Option exercise | +10,000 | $18.00 | $180,000 | 55,914 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2022-03-01 | Sale | −6,738 | $41.46 | $279,371 | 49,176 | D |
| Derivatives | |||||||
| Hopper Jonathan Mark Chief Medical Officer | 2022-03-01 | Option exercise · Stock Option (right to buy) | −10,000 | 37,604 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2022-03-01 | Option exercise · Stock Option (right to buy) | −10,000 | 38,750 | D | ||
| Open-market sales · 16,738 sh · avg $41.43 · $693,431 | |||||||
Loading xslF345X03/primary_01.xml…